Success Stories: An Epidemiologist Hailing from Nepal Obtains NIW Approval Without RFE, Thanks to Our Team’s Help in the Case Preparation

 

Client’s Testimonial:

“Your help was vital for the approval of my application.”


On February 26th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for an Epidemiologist III in the Field of Epidemiology (Approval Notice).


General Field: Epidemiology

Position at the Time of Case Filing: Epidemiologist III

Country of Origin: Nepal

State of Residence at the Time of Filing: Florida

Approval Notice Date: February 26th, 2023

Processing Time: 2 months, 29 days


Case Summary:

The National Interest Waiver or EB2-NIW is a subcategory of the nonimmigrant visa under EB2, which is granted to those foreign nationals who can prove the value of their work for the U.S.A. Our firm assists individuals who want to file their immigrant or nonimmigrant visas at the USCIS.

One of the things that we have picked up over the years of service is that academic and professional excellence goes a long way in getting approval quickly. So when we got an NIW request from an epidemiologist III hailing from Nepal, we did a quick survey of his documents to find whether he was the right fit for the case. Once this was done, we signed the retainer with him and began collecting relevant data such as:

  • As an expert in the field of epidemiology, his proposed endeavor is to continue his research on identifying at-risk persons and the underlying factors contributing to substance abuse through advanced epidemiological studies, statistical analysis, and characterization strategies. This would aid to control the long-term health, social, and economic burden of the dangerous and risky behaviors associated with addiction.
  • His research endeavor is of great importance because it is applicable to a variety of health concerns in the United States.
  • This proposed endeavor also has broad implications for the United States where the burden of healthcare complications invoked by chronic tobacco use and tobacco exposure is massive.
  • He has also completed at least 7 reviews to date and his research has resulted in 18 peer-reviewed journal articles (4 of them first-authored) which have been cited a total of 42 times according to Google Scholar.
  • The National Institutes of Health’s National Institute on Drug Abuse has also lent its support for the continuation of his work in the area.
  • Additionally, he has pursued research directly related to his proposed endeavor of identifying at-risk persons and the underlying factors contributing to substance abuse to control the burden of addiction for 5 years. This has given him the necessary experience to continue working in the field.
  • Finally, he also obtained 2 letters of recommendation which corroborated his work for the United States further.
These factors went a long way in proving the value of his work for the country winning him the approval in less than 3 months. We are glad that we could assist him in this process and we wish him the best of luck.